Research Programme: nucleotide-competing reverse transcriptase inhibitors - TibotecAlternative Names: NCRTI-1
Latest Information Update: 20 Feb 2008
At a glance
- Originator McGill University; Tibotec BVBA
- Class Pyridones; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical HIV infections